Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
45 hedge funds and large institutions have $4.24M invested in Ampio Pharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 14 closing their positions.
17% more call options, than puts
Call options by funds: $35K | Put options by funds: $30K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
7% less capital invested
Capital invested by funds: $4.55M → $4.24M (-$305K)
20% less funds holding
Funds holding: 56 → 45 (-11)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$8.07K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$7.44K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
+$6.33K |
| 4 |
BlackRock
New York
|
+$6.02K |
| 5 |
VF
Virtu Financial
New York
|
+$5.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Legal & General Group
London,
United Kingdom
|
-$170K |
| 2 |
ECM
Element Capital Management
New York
|
-$151K |
| 3 |
Goldman Sachs
New York
|
-$148K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$94K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$82K |
AMPE Hedge Fund Activity: Q3 2017 in Review
45 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2017, worth a combined $4.24M — down 6.7% from $4.55M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of AMPE and 4 opened new positions — a net loss of 10 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was United Capital Financial Advisors, opening a new position worth an estimated $8.07K. The largest seller was Legal & General Group, exiting entirely with an estimated $170K sold.
- 45 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2017, down from 56 in Q2 2017.
- Funds reported $4.24M of Ampio Pharmaceuticals Inc. stock for Q3 2017, down 6.7% quarter-over-quarter.
- 4 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2017 and 14 closed out, a net change of -10 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2017 was United Capital Financial Advisors, an estimated $8.07K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2017 was Legal & General Group, an estimated $170K sold.
Based on aggregated 13F filings for Q3 2017.